Abstract:This study depicted the metabolite and microbiota trajectories across aging. Long‐lived subjects from the familial longevity cohort harbored a distinguished microbiome signature. A candidate metabolite, pinane thromboxane A2 (PTA2), was consistently higher in the individuals of familial longevity and their descendants. Functional analysis showed PTA2 enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Our findings provide insights into the association between gut microbiome and longevity and may facilitate the development of strategies for healthy aging. Gut microbiota associated with longevity plays an important role in the adaptation to damaging stimuli accumulated during the aging process. The mechanism by which the longevity‐associated microbiota protects the senescent host remains unclear, while the metabolites of the gut bacteria are of particular interest. Here, an integrated analysis of untargeted metabolomics and 16S rRNA gene sequencing was used to characterize the metabolite and microbiota profiles of long‐lived individuals (aged ≥90 years) in comparison to old‐elderly (aged 75–89 years), young‐elderly (aged 60–74 years), and young to middle‐aged (aged ≤59 years) individuals. This novel study constructed both metabolite and microbiota trajectories across aging in populations from Jiaoling county (the seventh longevity town of the world) in China. We found that the long‐lived group exhibited remarkably differential metabolomic signatures, highlighting the existence of metabolic heterogeneity with aging. Importantly, we also discovered that long‐lived individuals from the familial longevity cohort harbored a microbiome distinguished from that of the general population. Specifically, we identified that the levels of a candidate metabolite, pinane thromboxane A2 (PTA2), which is positively associated with aging, were consistently higher in individuals with familial longevity and their younger descendants than in those of the general population. Furtherly, functional analysis revealed that PTA2 potentiated the efficiency of microglial phagocytosis of β‐amyloid 40 and enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Collectively, our results improve the understanding of the role of the gut microbiome in longevity and may facilitate the development of strategies for healthy aging.

Lipidomics of familial longevity

Improved Lipids, Diastolic Pressure and Kidney Function Are Potential Contributors to Familial Longevity: a Study on 60 Chinese Centenarian Families

Plasma triacylglycerol length and saturation level mark healthy aging groups in humans

Identification and Replication of Novel Genetic Variants of ABO Gene to Reduce the Incidence of Diseases and Promote Longevity by Modulating Lipid Homeostasis.

Fat metabolism is associated with telomere length in six population-based studies

Age and sex are associated with the plasma lipidome: findings from the GOLDN study

159-LB: The Lipidomic Signature of Prediabetes among the Oldest Old—The Long Life Family Study

The Effects of Age and Reproduction on the Lipidome of Caenorhabditis elegans

Dynamic lipidome alterations associated with human health, disease and ageing

Lipid Droplets and Peroxisomes Are Co-Regulated to Drive Lifespan Extension in Response to Mono-Unsaturated Fatty Acids

Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study

Change in lipids before onset of dementia, coronary heart disease, and mortality: A 28-year follow-up Whitehall II prospective cohort study

A lipidome landscape of aging in mice

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging

[Relationship Between Blood Lipid Level and Apolipoprotein E Gene Polymorphism in Offspring from Longevity and Non-Longevity Families].

Plasma proteomic signature of human longevity

The Age-Accompanied and Diet-Associated Remodeling of the Phospholipid, Amino Acid, and SCFA Metabolism of Healthy Centenarians from a Chinese Longevous Region: A Window into Exceptional Longevity

Plasma metabolomic profiles associated with mortality and longevity in a prospective analysis of 13,512 individuals

Associations of Triglyceride Levels with Longevity and Frailty: A Mendelian Randomization Analysis

Causal analysis identifies small HDL particles and physical activity as key determinants of longevity of older adults

Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study